APO Research
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Vaccine Adjuvants

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.

Selected research

Industry Growth & Trends

Global Veterinary Vaccine Adjuvants Industry Growth and Trends Forecast to 2032

26 December 202592 pages

Choose your research edition.

Industry ResearchVeterinary Vaccine Adjuvants Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Vaccine Adjuvants Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Veterinary Vaccine Adjuvants Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Vaccine Adjuvants Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Vaccine Adjuvants Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.

Europe is the largest region of Veterinary Vaccine Adjuvants, with a market share about 35%. It was followed by North America with 30%. SEPPIC, SDA BIO, Brenntag Biosector, SPI Pharma and MVP Laboratories are the top 5 manufacturers of industry, and they had about 70% combined market share.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Veterinary Vaccine Adjuvants market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Veterinary Vaccine Adjuvants market size, estimates, and forecasts are presented in terms of sales volume (t) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Veterinary Vaccine Adjuvants market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Veterinary Vaccine Adjuvants.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Veterinary Vaccine Adjuvants market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Veterinary Vaccine Adjuvants Market by Company

SEPPIC

SDA BIO

Croda International Plc

SPI Pharma

MVP Laboratories

Zhuoyue

Zhiju Bio

Veterinary Vaccine Adjuvants Segment by Type

Oral

Subcutaneous

Intramuscular

Others

Veterinary Vaccine Adjuvants Segment by Application

Livestock Vaccines

Companion Animals Vaccines

Veterinary Vaccine Adjuvants Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Vaccine Adjuvants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Vaccine Adjuvants and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Vaccine Adjuvants.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Veterinary Vaccine Adjuvants manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Veterinary Vaccine Adjuvants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oral Table 2. Major Company of Subcutaneous Table 3. Major Company of Intramuscular Table 4. Major Company of Others Table 5. Global Veterinary Vaccine Adjuvants Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Veterinary Vaccine Adjuvants Sales by Type (2021-2026) & (t) Table 7. Global Veterinary Vaccine Adjuvants Sales Market Share in Volume by Type (2021-2026) Table 8. Global Veterinary Vaccine Adjuvants Sales by Type (2021-2026) & (US$ Million) Table 9. Global Veterinary Vaccine Adjuvants Sales Market Share in Value by Type (2021-2026) Table 10. Global Veterinary Vaccine Adjuvants Price by Type (2021-2026) & (USD/kg) Table 11. Global Veterinary Vaccine Adjuvants Sales by Type (2027-2032) & (t) Table 12. Global Veterinary Vaccine Adjuvants Sales Market Share in Volume by Type (2027-2032) Table 13. Global Veterinary Vaccine Adjuvants Sales by Type (2027-2032) & (US$ Million) Table 14. Global Veterinary Vaccine Adjuvants Sales Market Share in Value by Type (2027-2032) Table 15. Global Veterinary Vaccine Adjuvants Price by Type (2027-2032) & (USD/kg) Table 16. North America Veterinary Vaccine Adjuvants Sales by Type (2021-2026) & (t) Table 17. North America Veterinary Vaccine Adjuvants Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Veterinary Vaccine Adjuvants Sales by Type (2021-2026) & (t) Table 19. Europe Veterinary Vaccine Adjuvants Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Veterinary Vaccine Adjuvants Sales by Type (2021-2026) & (t) Table 21. Asia-Pacific Veterinary Vaccine Adjuvants Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Veterinary Vaccine Adjuvants Sales by Type (2021-2026) & (t) Table 23. Latin America Veterinary Vaccine Adjuvants Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Veterinary Vaccine Adjuvants Sales by Type (2021-2026) & (t) Table 25. Middle East and Africa Veterinary Vaccine Adjuvants Sales by Type (2021-2026) & (US$ Million) Table 26. Veterinary Vaccine Adjuvants Industry Trends Table 27. Veterinary Vaccine Adjuvants Industry Drivers Table 28. Veterinary Vaccine Adjuvants Industry Opportunities and Challenges Table 29. Veterinary Vaccine Adjuvants Industry Restraints Table 30. Global Veterinary Vaccine Adjuvants Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Veterinary Vaccine Adjuvants Revenue Market Share by Company (2021-2026) Table 32. Global Veterinary Vaccine Adjuvants Sales by Company (2021-2026) & (t) Table 33. Global Veterinary Vaccine Adjuvants Sales Share by Company (2021-2026) Table 34. Global Veterinary Vaccine Adjuvants Market Price by Company (2021-2026) & (USD/kg) Table 35. Global Veterinary Vaccine Adjuvants Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Veterinary Vaccine Adjuvants Major Company Production Sites and Headquarters Table 37. Global Veterinary Vaccine Adjuvants Company, Product Type & Application Table 38. Global Veterinary Vaccine Adjuvants Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Veterinary Vaccine Adjuvants by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Veterinary Vaccine Adjuvants Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Veterinary Vaccine Adjuvants Sales by Region (2021-2026) & (t) Table 43. Global Veterinary Vaccine Adjuvants Sales Market Share in Volume by Region (2021-2026) Table 44. Global Veterinary Vaccine Adjuvants Sales by Region (2021-2026) & (US$ Million) Table 45. Global Veterinary Vaccine Adjuvants Sales Market Share in Value by Region (2021-2026) Table 46. Global Veterinary Vaccine Adjuvants Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 47. Global Veterinary Vaccine Adjuvants Sales by Region (2027-2032) & (t) Table 48. Global Veterinary Vaccine Adjuvants Sales Market Share in Volume by Region (2027-2032) Table 49. Global Veterinary Vaccine Adjuvants Sales by Region (2027-2032) & (US$ Million) Table 50. Global Veterinary Vaccine Adjuvants Sales Market Share in Value by Region (2027-2032) Table 51. Global Veterinary Vaccine Adjuvants Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2027-2032) Table 52. Global Veterinary Vaccine Adjuvants Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Veterinary Vaccine Adjuvants Sales by Application (2021-2026) & (t) Table 54. Global Veterinary Vaccine Adjuvants Sales Market Share in Volume by Application (2021-2026) Table 55. Global Veterinary Vaccine Adjuvants Sales by Application (2021-2026) & (US$ Million) Table 56. Global Veterinary Vaccine Adjuvants Sales Market Share in Value by Application (2021-2026) Table 57. Global Veterinary Vaccine Adjuvants Price by Application (2021-2026) & (USD/kg) Table 58. Global Veterinary Vaccine Adjuvants Sales by Application (2027-2032) & (t) Table 59. Global Veterinary Vaccine Adjuvants Sales Market Share in Volume by Application (2027-2032) Table 60. Global Veterinary Vaccine Adjuvants Sales by Application (2027-2032) & (US$ Million) Table 61. Global Veterinary Vaccine Adjuvants Sales Market Share in Value by Application (2027-2032) Table 62. Global Veterinary Vaccine Adjuvants Price by Application (2027-2032) & (USD/kg) Table 63. North America Veterinary Vaccine Adjuvants Sales by Application (2021-2026) & (t) Table 64. North America Veterinary Vaccine Adjuvants Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Veterinary Vaccine Adjuvants Sales by Application (2021-2026) & (t) Table 66. Europe Veterinary Vaccine Adjuvants Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Veterinary Vaccine Adjuvants Sales by Application (2021-2026) & (t) Table 68. Asia-Pacific Veterinary Vaccine Adjuvants Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Veterinary Vaccine Adjuvants Sales by Application (2021-2026) & (t) Table 70. Latin America Veterinary Vaccine Adjuvants Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Veterinary Vaccine Adjuvants Sales by Application (2021-2026) & (t) Table 72. Middle East and Africa Veterinary Vaccine Adjuvants Sales by Application (2021-2026) & (US$ Million) Table 73. SEPPIC Company Information Table 74. SEPPIC Business Overview Table 75. SEPPIC Veterinary Vaccine Adjuvants Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 76. SEPPIC Veterinary Vaccine Adjuvants Product Portfolio Table 77. SEPPIC Recent Development Table 78. SDA BIO Company Information Table 79. SDA BIO Business Overview Table 80. SDA BIO Veterinary Vaccine Adjuvants Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 81. SDA BIO Veterinary Vaccine Adjuvants Product Portfolio Table 82. SDA BIO Recent Development Table 83. Croda International Plc Company Information Table 84. Croda International Plc Business Overview Table 85. Croda International Plc Veterinary Vaccine Adjuvants Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 86. Croda International Plc Veterinary Vaccine Adjuvants Product Portfolio Table 87. Croda International Plc Recent Development Table 88. SPI Pharma Company Information Table 89. SPI Pharma Business Overview Table 90. SPI Pharma Veterinary Vaccine Adjuvants Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 91. SPI Pharma Veterinary Vaccine Adjuvants Product Portfolio Table 92. SPI Pharma Recent Development Table 93. MVP Laboratories Company Information Table 94. MVP Laboratories Business Overview Table 95. MVP Laboratories Veterinary Vaccine Adjuvants Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 96. MVP Laboratories Veterinary Vaccine Adjuvants Product Portfolio Table 97. MVP Laboratories Recent Development Table 98. Zhuoyue Company Information Table 99. Zhuoyue Business Overview Table 100. Zhuoyue Veterinary Vaccine Adjuvants Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 101. Zhuoyue Veterinary Vaccine Adjuvants Product Portfolio Table 102. Zhuoyue Recent Development Table 103. Zhiju Bio Company Information Table 104. Zhiju Bio Business Overview Table 105. Zhiju Bio Veterinary Vaccine Adjuvants Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 106. Zhiju Bio Veterinary Vaccine Adjuvants Product Portfolio Table 107. Zhiju Bio Recent Development Table 108. North America Veterinary Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 109. North America Veterinary Vaccine Adjuvants Sales by Country (2021-2026) & (t) Table 110. North America Veterinary Vaccine Adjuvants Sales Market Share by Country (2021-2026) Table 111. North America Veterinary Vaccine Adjuvants Sales Forecast by Country (2027-2032) & (t) Table 112. North America Veterinary Vaccine Adjuvants Sales Market Share Forecast by Country (2027-2032) Table 113. North America Veterinary Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. North America Veterinary Vaccine Adjuvants Market Size by Country (2021-2026) & (US$ Million) Table 115. North America Veterinary Vaccine Adjuvants Market Share by Country (2021-2026) Table 116. North America Veterinary Vaccine Adjuvants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. North America Veterinary Vaccine Adjuvants Market Share Forecast by Country (2027-2032) Table 118. Europe Veterinary Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 119. Europe Veterinary Vaccine Adjuvants Sales by Country (2021-2026) & (t) Table 120. Europe Veterinary Vaccine Adjuvants Sales Market Share by Country (2021-2026) Table 121. Europe Veterinary Vaccine Adjuvants Sales Forecast by Country (2027-2032) & (t) Table 122. Europe Veterinary Vaccine Adjuvants Sales Market Share Forecast by Country (2027-2032) Table 123. Europe Veterinary Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Europe Veterinary Vaccine Adjuvants Market Size by Country (2021-2026) & (US$ Million) Table 125. Europe Veterinary Vaccine Adjuvants Market Share by Country (2021-2026) Table 126. Europe Veterinary Vaccine Adjuvants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Europe Veterinary Vaccine Adjuvants Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific Veterinary Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific Veterinary Vaccine Adjuvants Sales by Country (2021-2026) & (t) Table 130. Asia-Pacific Veterinary Vaccine Adjuvants Sales Market Share by Country (2021-2026) Table 131. Asia-Pacific Veterinary Vaccine Adjuvants Sales Forecast by Country (2027-2032) & (t) Table 132. Asia-Pacific Veterinary Vaccine Adjuvants Sales Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Veterinary Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Veterinary Vaccine Adjuvants Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Veterinary Vaccine Adjuvants Market Share by Country (2021-2026) Table 136. Asia-Pacific Veterinary Vaccine Adjuvants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Veterinary Vaccine Adjuvants Market Share Forecast by Country (2027-2032) Table 138. Latin America Veterinary Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 139. Latin America Veterinary Vaccine Adjuvants Sales by Country (2021-2026) & (t) Table 140. Latin America Veterinary Vaccine Adjuvants Sales Market Share by Country (2021-2026) Table 141. Latin America Veterinary Vaccine Adjuvants Sales Forecast by Country (2027-2032) & (t) Table 142. Latin America Veterinary Vaccine Adjuvants Sales Market Share Forecast by Country (2027-2032) Table 143. Latin America Veterinary Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Latin America Veterinary Vaccine Adjuvants Market Size by Country (2021-2026) & (US$ Million) Table 145. Latin America Veterinary Vaccine Adjuvants Market Share by Country (2021-2026) Table 146. Latin America Veterinary Vaccine Adjuvants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Latin America Veterinary Vaccine Adjuvants Market Share Forecast by Country (2027-2032) Table 148. Middle East and Africa Veterinary Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 149. Middle East and Africa Veterinary Vaccine Adjuvants Sales by Country (2021-2026) & (t) Table 150. Middle East and Africa Veterinary Vaccine Adjuvants Sales Market Share by Country (2021-2026) Table 151. Middle East and Africa Veterinary Vaccine Adjuvants Sales Forecast by Country (2027-2032) & (t) Table 152. Middle East and Africa Veterinary Vaccine Adjuvants Sales Market Share Forecast by Country (2027-2032) Table 153. Middle East and Africa Veterinary Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Middle East and Africa Veterinary Vaccine Adjuvants Market Size by Country (2021-2026) & (US$ Million) Table 155. Middle East and Africa Veterinary Vaccine Adjuvants Market Share by Country (2021-2026) Table 156. Middle East and Africa Veterinary Vaccine Adjuvants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Middle East and Africa Veterinary Vaccine Adjuvants Market Share Forecast by Country (2027-2032) Table 158. Key Raw Materials Table 159. Raw Materials Key Suppliers Table 160. Veterinary Vaccine Adjuvants Distributors List Table 161. Veterinary Vaccine Adjuvants Customers List Table 162. Research Programs/Design for This Report Table 163. Authors List of This Report Table 164. Secondary Sources Table 165. Primary Sources List of Figures Figure 1. Veterinary Vaccine Adjuvants Image Figure 2. Global Veterinary Vaccine Adjuvants Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Vaccine Adjuvants Market Size (2021-2032) & (US$ Million) Figure 4. Global Veterinary Vaccine Adjuvants Sales (2021-2032) & (t) Figure 5. Oral Image Figure 6. Global Oral Sales YoY Growth (2021-2032) & (t) Figure 7. Subcutaneous Image Figure 8. Global Subcutaneous Sales YoY Growth (2021-2032) & (t) Figure 9. Intramuscular Image Figure 10. Global Intramuscular Sales YoY Growth (2021-2032) & (t) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (t) Figure 13. Global Veterinary Vaccine Adjuvants Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Veterinary Vaccine Adjuvants Market Share by Type 2025 VS 2032 Figure 15. North America Veterinary Vaccine Adjuvants Sales Market Share in Volume by Type in 2025 Figure 16. North America Veterinary Vaccine Adjuvants Sales Market Share in Value by Type in 2025 Figure 17. Europe Veterinary Vaccine Adjuvants Sales Market Share in Volume by Type in 2025 Figure 18. Europe Veterinary Vaccine Adjuvants Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Veterinary Vaccine Adjuvants Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Veterinary Vaccine Adjuvants Sales Market Share in Value by Type in 2025 Figure 21. Latin America Veterinary Vaccine Adjuvants Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Veterinary Vaccine Adjuvants Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Veterinary Vaccine Adjuvants Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Veterinary Vaccine Adjuvants Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Veterinary Vaccine Adjuvants Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Livestock Vaccines Image Figure 28. Global Livestock Vaccines Sales YoY Growth (2021-2032) & (t) Figure 29. Companion Animals Vaccines Image Figure 30. Global Companion Animals Vaccines Sales YoY Growth (2021-2032) & (t) Figure 31. Global Veterinary Vaccine Adjuvants Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Veterinary Vaccine Adjuvants Market Share by Application 2025 VS 2032 Figure 33. North America Veterinary Vaccine Adjuvants Sales Market Share in Volume by Application in 2025 Figure 34. North America Veterinary Vaccine Adjuvants Sales Market Share in Value by Application in 2025 Figure 35. Europe Veterinary Vaccine Adjuvants Sales Market Share in Volume by Application in 2025 Figure 36. Europe Veterinary Vaccine Adjuvants Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Veterinary Vaccine Adjuvants Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Veterinary Vaccine Adjuvants Sales Market Share in Value by Application in 2025 Figure 39. Latin America Veterinary Vaccine Adjuvants Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Veterinary Vaccine Adjuvants Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Veterinary Vaccine Adjuvants Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Veterinary Vaccine Adjuvants Sales Market Share in Value by Application in 2025 Figure 43. North America Veterinary Vaccine Adjuvants Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 44. North America Veterinary Vaccine Adjuvants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Veterinary Vaccine Adjuvants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Veterinary Vaccine Adjuvants Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Veterinary Vaccine Adjuvants Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 48. Europe Veterinary Vaccine Adjuvants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Veterinary Vaccine Adjuvants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Veterinary Vaccine Adjuvants Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Veterinary Vaccine Adjuvants Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 52. Asia-Pacific Veterinary Vaccine Adjuvants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Veterinary Vaccine Adjuvants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Veterinary Vaccine Adjuvants Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Veterinary Vaccine Adjuvants Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 56. Latin America Veterinary Vaccine Adjuvants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Veterinary Vaccine Adjuvants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Veterinary Vaccine Adjuvants Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Veterinary Vaccine Adjuvants Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 60. Middle East and Africa Veterinary Vaccine Adjuvants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Veterinary Vaccine Adjuvants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Veterinary Vaccine Adjuvants Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Veterinary Vaccine Adjuvants Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Veterinary Vaccine Adjuvants Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Subcutaneous
  • Intramuscular
  • Others
Applications
  • Livestock Vaccines
  • Companion Animals Vaccines
Companies covered
  • SEPPIC
  • SDA BIO
  • Croda International Plc
  • SPI Pharma
  • MVP Laboratories
  • Zhuoyue
  • Zhiju Bio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Veterinary Vaccine Adjuvants Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Veterinary Vaccine Adjuvants Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Veterinary Vaccine Adjuvants Market by Type
  6. 1.3.1 Oral
  7. 1.3.2 Subcutaneous
  8. 1.3.3 Intramuscular
  9. 1.3.4 Others
  10. 1.4 Global Veterinary Vaccine Adjuvants Market Size by Type
  11. 1.4.1 Global Veterinary Vaccine Adjuvants Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Veterinary Vaccine Adjuvants Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Veterinary Vaccine Adjuvants Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Veterinary Vaccine Adjuvants Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Veterinary Vaccine Adjuvants Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Veterinary Vaccine Adjuvants Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Veterinary Vaccine Adjuvants Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Veterinary Vaccine Adjuvants Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Veterinary Vaccine Adjuvants Industry Trends
  2. 2.2 Veterinary Vaccine Adjuvants Industry Drivers
  3. 2.3 Veterinary Vaccine Adjuvants Industry Opportunities and Challenges
  4. 2.4 Veterinary Vaccine Adjuvants Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Veterinary Vaccine Adjuvants Revenue (2021-2026)
  2. 3.2 Global Top Players by Veterinary Vaccine Adjuvants Sales (2021-2026)
  3. 3.3 Global Top Players by Veterinary Vaccine Adjuvants Price (2021-2026)
  4. 3.4 Global Veterinary Vaccine Adjuvants Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Veterinary Vaccine Adjuvants Major Company Production Sites & Headquarters
  6. 3.6 Global Veterinary Vaccine Adjuvants Company, Product Type & Application
  7. 3.7 Global Veterinary Vaccine Adjuvants Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Veterinary Vaccine Adjuvants Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Veterinary Vaccine Adjuvants Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Veterinary Vaccine Adjuvants Tier 1, Tier 2, and Tier 3
4 Veterinary Vaccine Adjuvants Regional Status and Outlook
  1. 4.1 Global Veterinary Vaccine Adjuvants Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Veterinary Vaccine Adjuvants Historic Market Size by Region
  3. 4.2.1 Global Veterinary Vaccine Adjuvants Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Veterinary Vaccine Adjuvants Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Veterinary Vaccine Adjuvants Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Veterinary Vaccine Adjuvants Forecasted Market Size by Region
  7. 4.3.1 Global Veterinary Vaccine Adjuvants Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Veterinary Vaccine Adjuvants Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Veterinary Vaccine Adjuvants Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Veterinary Vaccine Adjuvants by Application
  1. 5.1 Veterinary Vaccine Adjuvants Market by Application
  2. 5.1.1 Livestock Vaccines
  3. 5.1.2 Companion Animals Vaccines
  4. 5.2 Global Veterinary Vaccine Adjuvants Market Size by Application
  5. 5.2.1 Global Veterinary Vaccine Adjuvants Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Veterinary Vaccine Adjuvants Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Veterinary Vaccine Adjuvants Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Veterinary Vaccine Adjuvants Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Veterinary Vaccine Adjuvants Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Veterinary Vaccine Adjuvants Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Veterinary Vaccine Adjuvants Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Veterinary Vaccine Adjuvants Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 SEPPIC
  2. 6.1.1 SEPPIC Company Information
  3. 6.1.2 SEPPIC Business Overview
  4. 6.1.3 SEPPIC Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 SEPPIC Veterinary Vaccine Adjuvants Product Portfolio
  6. 6.1.5 SEPPIC Recent Developments
  7. 6.2 SDA BIO
  8. 6.2.1 SDA BIO Company Information
  9. 6.2.2 SDA BIO Business Overview
  10. 6.2.3 SDA BIO Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 SDA BIO Veterinary Vaccine Adjuvants Product Portfolio
  12. 6.2.5 SDA BIO Recent Developments
  13. 6.3 Croda International Plc
  14. 6.3.1 Croda International Plc Company Information
  15. 6.3.2 Croda International Plc Business Overview
  16. 6.3.3 Croda International Plc Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Croda International Plc Veterinary Vaccine Adjuvants Product Portfolio
  18. 6.3.5 Croda International Plc Recent Developments
  19. 6.4 SPI Pharma
  20. 6.4.1 SPI Pharma Company Information
  21. 6.4.2 SPI Pharma Business Overview
  22. 6.4.3 SPI Pharma Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 SPI Pharma Veterinary Vaccine Adjuvants Product Portfolio
  24. 6.4.5 SPI Pharma Recent Developments
  25. 6.5 MVP Laboratories
  26. 6.5.1 MVP Laboratories Company Information
  27. 6.5.2 MVP Laboratories Business Overview
  28. 6.5.3 MVP Laboratories Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 MVP Laboratories Veterinary Vaccine Adjuvants Product Portfolio
  30. 6.5.5 MVP Laboratories Recent Developments
  31. 6.6 Zhuoyue
  32. 6.6.1 Zhuoyue Company Information
  33. 6.6.2 Zhuoyue Business Overview
  34. 6.6.3 Zhuoyue Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Zhuoyue Veterinary Vaccine Adjuvants Product Portfolio
  36. 6.6.5 Zhuoyue Recent Developments
  37. 6.7 Zhiju Bio
  38. 6.7.1 Zhiju Bio Company Information
  39. 6.7.2 Zhiju Bio Business Overview
  40. 6.7.3 Zhiju Bio Veterinary Vaccine Adjuvants Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Zhiju Bio Veterinary Vaccine Adjuvants Product Portfolio
  42. 6.7.5 Zhiju Bio Recent Developments
7 North America by Country
  1. 7.1 North America Veterinary Vaccine Adjuvants Sales by Country
  2. 7.1.1 North America Veterinary Vaccine Adjuvants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Veterinary Vaccine Adjuvants Sales by Country (2021-2026)
  4. 7.1.3 North America Veterinary Vaccine Adjuvants Sales Forecast by Country (2027-2032)
  5. 7.2 North America Veterinary Vaccine Adjuvants Market Size by Country
  6. 7.2.1 North America Veterinary Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Veterinary Vaccine Adjuvants Market Size by Country (2021-2026)
  8. 7.2.3 North America Veterinary Vaccine Adjuvants Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Veterinary Vaccine Adjuvants Sales by Country
  2. 8.1.1 Europe Veterinary Vaccine Adjuvants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Veterinary Vaccine Adjuvants Sales by Country (2021-2026)
  4. 8.1.3 Europe Veterinary Vaccine Adjuvants Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Veterinary Vaccine Adjuvants Market Size by Country
  6. 8.2.1 Europe Veterinary Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Veterinary Vaccine Adjuvants Market Size by Country (2021-2026)
  8. 8.2.3 Europe Veterinary Vaccine Adjuvants Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Veterinary Vaccine Adjuvants Sales by Country
  2. 9.1.1 Asia-Pacific Veterinary Vaccine Adjuvants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Veterinary Vaccine Adjuvants Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Veterinary Vaccine Adjuvants Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Veterinary Vaccine Adjuvants Market Size by Country
  6. 9.2.1 Asia-Pacific Veterinary Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Veterinary Vaccine Adjuvants Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Veterinary Vaccine Adjuvants Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Veterinary Vaccine Adjuvants Sales by Country
  2. 10.1.1 South America Veterinary Vaccine Adjuvants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Veterinary Vaccine Adjuvants Sales by Country (2021-2026)
  4. 10.1.3 South America Veterinary Vaccine Adjuvants Sales Forecast by Country (2027-2032)
  5. 10.2 South America Veterinary Vaccine Adjuvants Market Size by Country
  6. 10.2.1 South America Veterinary Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Veterinary Vaccine Adjuvants Market Size by Country (2021-2026)
  8. 10.2.3 South America Veterinary Vaccine Adjuvants Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Veterinary Vaccine Adjuvants Sales by Country
  2. 11.1.1 Middle East and Africa Veterinary Vaccine Adjuvants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Veterinary Vaccine Adjuvants Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Veterinary Vaccine Adjuvants Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Veterinary Vaccine Adjuvants Market Size by Country
  6. 11.2.1 Middle East and Africa Veterinary Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Veterinary Vaccine Adjuvants Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Veterinary Vaccine Adjuvants Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Veterinary Vaccine Adjuvants Value Chain Analysis
  2. 12.1.1 Veterinary Vaccine Adjuvants Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Veterinary Vaccine Adjuvants Production Mode & Process
  7. 12.2 Veterinary Vaccine Adjuvants Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Veterinary Vaccine Adjuvants Distributors
  10. 12.2.3 Veterinary Vaccine Adjuvants Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst